Press Releases

01 Nov '18
Reported third quarter growth of 16% in GAAP revenue to $522 million , 19% in non-GAAP revenue to $536 million Third quarter GAAP loss per share of $0.20 , growth of 13% in non-GAAP EPS to $0.18 Year-to-date growth of 21% in GAAP revenue to $1,562 million , 23% in non-GAAP revenue to $1,590 million
25 Oct '18
New Offering from CoverMyMeds and RelayHealth Pharmacy Solutions Will Provide Accurate Prescription Price Information, Prescribing Decision Support and Streamlined Medication Access CHICAGO, Oct. 25, 2018 (GLOBE NEWSWIRE) -- Today, Allscripts (NASDAQ:MDRX), a global leader in health care
17 Sep '18
Adds innovative software technology for hospital capital budgeting to EPSi Platform CHICAGO , Sept. 17, 2018 (GLOBE NEWSWIRE) -- EPSi, Allscripts (NASDAQ: MDRX) flagship budgeting, long-range planning, cost accounting and financial decision support platform, announced a partnership with Ilerasoft,
13 Sep '18
New Performance Analytics for Risk-based Contracts and Medicare Payments to extend EPSi Platform Capabilities CHICAGO , Sept. 13, 2018 (GLOBE NEWSWIRE) -- EPSi, Allscripts (NASDAQ: MDRX) flagship budgeting, long-range planning, cost accounting and financial decision support platform, announced a

Contact Investor Relations

Stephen Shulstein
Vice President, Investor Relations
Stephen.Shulstein@allscripts.com